Asia Pacific Cell Therapy Market expected to boost the revenue generation by 2028
Asia Pacific Cell Therapy Industry Overview The Asia Pacific cell therapy market size was valued at USD 959.8 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.9% from 2021 to 2028. The development of stem cell banking facilities and the resultant increase in stem cell production is expected to improve the volumetric capabilities of the market at a regional and country level. This, in turn, is anticipated to drive the market. Moreover, advancements in the therapy landscape with respect to their efficiency and manufacturing are some other major drivers of the market. Gather more insights about the market drivers, restrains and growth of the Asia Pacific Cell Therapy Market Furthermore, according to some studies and evidence, it was found that increased levels of cytokines and chemokines that target lung tissue are due to some etiological factors. Mesenchymal Stem Cell (MSC)-derived exosomes are considered to have potential therapeutic act...